T-cell exhaustion is a state of T-cell differentiation that develops during prolonged exposure to an antigen, particularly in chronic infections and cancer. It is characterized by altered functional responses, sustained expression of multiple inhibitory receptors, and distinctive transcriptional and epigenetic programs. Exhausted T cells are not simply inactive or depleted: many retain important protective functions, and different subsets have different capacities for proliferation, persistence, and response to immunotherapy. The phenomenon is best characterized in CD8 T cells, although related states occur in CD4 T cells.
Biological context and discovery
During an acute infection, antigen recognition activates antigen-specific T cells, which multiply and acquire effector functions. CD8 T cells can kill infected cells, while CD4 T cells coordinate other immune responses. After antigen clearance, most activated cells die, and a smaller population persists to support immunological memory.
When antigen persists, this sequence changes. Continued stimulation through the T-cell receptor, together with inflammatory and tissue-derived signals, can drive cells toward exhaustion rather than conventional effector or memory differentiation.
The concept emerged from studies of persistent lymphocytic choriomeningitis virus infection in mice. These experiments showed that virus-specific T cells could remain present while losing aspects of their antiviral activity. Subsequent research identified related states in human chronic viral infections and in tumor-infiltrating T cells.
Exhaustion can impair pathogen clearance and tumor control, but it also limits sustained immune-mediated tissue injury. It is therefore understood as both a constraint on immunity and an adaptation to persistent stimulation.
Defining characteristics
No single feature establishes that a T cell is exhausted. Identification depends on the combination of functional behavior, receptor expression, molecular state, and biological context.
Altered effector function
Exhausted cells commonly show reduced proliferative capacity and changes in the production of cytokines, including interleukin-2, tumor necrosis factor, and interferon-gamma. Their ability to perform several functions simultaneously is often diminished.
Classic chronic-infection models describe a progressive loss of functions, with proliferation and interleukin-2 production frequently affected before some other effector activities. This sequence is not universal. Exhausted cells may retain substantial cytotoxic activity, and some terminally differentiated subsets express high levels of molecules involved in killing target cells.
Inhibitory-receptor expression
Exhausted T cells often coexpress several immune checkpoint receptors, including PD-1, LAG-3, TIM-3, and TIGIT. These receptors regulate activation and can restrain responses under persistent stimulation.
Their expression alone is insufficient to diagnose exhaustion. PD-1, for example, also appears on recently activated T cells that remain functional. Sustained expression of several inhibitory receptors is more informative when accompanied by characteristic molecular and functional changes.
Distinctive gene regulation
Exhaustion involves a coordinated gene-expression program rather than the temporary suppression of a few functions. Changes in chromatin accessibility and other epigenetic features help stabilize this state.
The transcription factors TOX and members of the NR4A family participate in exhaustion-associated regulatory programs. Their effects depend on cellular context and differentiation stage. TOX, in particular, helps establish an exhaustion-associated state that also permits T-cell persistence during chronic stimulation.
Mechanisms
Persistent antigen signaling
Prolonged or repeated antigen recognition is a central driver. Antigen abundance, duration of exposure, receptor affinity, and anatomical location influence the resulting response. Persistent signaling engages regulatory pathways differently from the transient stimulation typical of an acute response.
The balance between activating signals, costimulation, and inhibitory signaling also shapes differentiation. Exhaustion cannot be attributed to a single receptor or signaling pathway.
The tissue environment
Local conditions can reinforce exhaustion. Within tumors, T cells may encounter poor nutrient availability, low oxygen, suppressive signaling molecules, and interactions with regulatory T cells or other immunoregulatory cells. These influences act together with persistent tumor-antigen recognition.
Not every dysfunctional T cell in a tumor is exhausted. Inadequate activation, exclusion from tumor tissue, nutrient limitation, and other mechanisms can reduce antitumor activity without producing the same differentiation program.
Metabolic changes
Exhaustion is associated with changes in metabolism, including impaired mitochondrial function and altered use of glucose and other nutrients. Such changes can restrict proliferation and effector activity while also reflecting the tissue environment.
Metabolic dysfunction and exhaustion-associated gene regulation influence one another. Neither a single metabolic defect nor nutrient shortage alone defines the exhausted state.
Major cellular subsets
Exhausted T-cell populations are heterogeneous. A widely used distinction separates progenitor-like cells from more differentiated exhausted cells, although terminology and markers vary across studies.
| Population | Common characteristics | Biological significance |
|---|---|---|
| Progenitor-like or stem-like exhausted T cells | Often express TCF1, encoded by TCF7, together with PD-1; retain self-renewal and proliferative potential | Sustain the response and can generate more differentiated descendants |
| Intermediate or transitory exhausted T cells | Show combinations of proliferative activity, effector function, and exhaustion-associated features | Can contribute substantially to ongoing immune activity |
| Terminally exhausted T cells | Usually show stronger inhibitory-receptor expression, reduced proliferative potential, and more fixed regulatory features | May retain cytotoxic functions but have limited capacity for sustained expansion |
These categories describe related cell states rather than a universally fixed sequence. Their abundance and behavior depend on tissue location, disease context, and experimental definitions.
Distinction from other forms of T-cell dysfunction
Exhaustion overlaps with, but is not equivalent to, several other processes:
- Anergy: Reduced responsiveness commonly established when antigen recognition occurs without adequate activating signals. Its initiating conditions and regulatory programs differ from those of classical exhaustion.
- Cellular senescence: A state associated with durable proliferative arrest and cellular stress. Some markers overlap, but exhausted and senescent T cells are not interchangeable categories.
- Apoptosis and deletion: Processes that remove cells. Exhaustion concerns altered differentiation and function in cells that remain present.
- Normal activation: Activated T cells can transiently express inhibitory receptors without acquiring a stable exhausted program.
Exhaustion can contribute to the broader regulation of immune tolerance, but it is not a synonym for tolerance.
Relevance to immunotherapy
Checkpoint-blocking antibodies, particularly those targeting PD-1 or its ligand PD-L1, can increase antitumor T-cell activity in some cancers. Their effects helped establish the clinical importance of exhaustion-associated inhibitory pathways.
Such treatment does not simply restore every exhausted cell to a normal memory state. Progenitor-like exhausted populations frequently provide an important source of proliferating cells after checkpoint blockade. More terminally differentiated cells generally have less capacity for durable expansion, and exhaustion-associated epigenetic features can persist despite functional improvement.
Response also depends on factors beyond exhaustion, including antigen presentation, tumor characteristics, and immune-cell access to the tumor. Exhaustion markers alone therefore do not reliably predict an individual patient's treatment response.
Measurement and interpretive limits
Researchers assess exhaustion using functional experiments, flow cytometry, tissue imaging, RNA sequencing, and chromatin profiling. Single-cell approaches help distinguish subsets that would otherwise be combined in bulk measurements.
A major limitation is the absence of a universal diagnostic marker or threshold. A population may have an exhaustion-associated transcriptional signature while retaining meaningful protective activity. Conversely, poor function in a laboratory assay does not by itself demonstrate exhaustion.
Results also depend on sampling: circulating T cells may differ markedly from cells in tumors, lymph nodes, or infected tissues. Findings from mouse infection models provide important mechanistic evidence, but their precise cellular trajectories and markers do not transfer unchanged to every human disease.